Physician profile
Najam Awan
NPI 1053446922
$1,583.11
in general payments reported to CMS, 2019-2025
18 companies · $74.56 in 2025
The $74.56 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $958 · 2020: $110 · 2021: $59.75 · 2022: $64.28 · 2023: $155 · 2024: $162 · 2025: $74.56.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $391.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $390.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $428.19 | 2019-2020 | |
| Amgen INC. | $278.84 | 2019-2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $220.85 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $91.44 | 2019 | |
| Merck Sharp & Dohme LLC | $75.48 | 2023-2024 | Verquvo |
| Astrazeneca Pharmaceuticals LP | $73.11 | 2023-2024 | Farxiga |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $64.40 | 2019-2025 | Lifevest |
| Lilly USA, LLC | $59.75 | 2021 | |
| Portola Pharmaceuticals, LLC | $49.56 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $42.47 | 2023 | Inpefa |
| Bardy Diagnostics, INC. | $36.82 | 2022 | |
| Boston Scientific Corporation | $30.25 | 2024 | Patientcare Link |
| Medtronic, INC. | $27.62 | 2024 | Micra |
| Lantheus Medical Imaging, INC. | $27.46 | 2022 | |
| Novartis Pharmaceuticals Corporation | $23.50 | 2024 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Irhythm Technologies, INC. | $20.47 | 2023 | Zio Xt Patch |
| Esperion Therapeutics, INC. | $20.45 | 2025 | Nexletol |
| Regeneron Healthcare Solutions, INC. | $12.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Najam Awan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.